Johnson & Johnson to Participate in Morgan Stanley Global Health Care Conference

NEW BRUNSWICK, N.J., Sept. 6, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley Global Health Care Conference Tuesday, September 13th, at the Grand Hyatt New York, 109 East 42nd Street at Grand Central, New York, NY.  Dominic Caruso, Vice President, Finance and Chief Financial Officer, Executive Committee for Johnson & Johnson, will represent the company in a session scheduled at 10:20 a.m. (Eastern).

This broadcast will be available to interested investors and parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available shortly after the live webcast.

SOURCE Johnson & Johnson

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.